Avirmax Biopharma

About Avirmax

About Us


Avirmax Biopharma, Inc. based in San Francisco Bay Area, is a preclinical stage biopharmaceutical company focusing on innovation and development of genetic medicines to treat chronic and degenerated ocular diseases using integrated solutions in engineering and optimization of adeno-associated virus (AAV) vectors, rich experience and knowledge in biopharmaceutical development and product supply. Our mission is to deliver patients with safe, effective, durable, affordable and accessible AAV-mediated biotherapeutics to preserve patient’s vision.

Our Mission

We are striving to become a powerhouse of AAV gene therapeutics via persistent innovation and diligent practice.

Our Vision

We are developing solutions to provide patients with effective, safe, affordable, and accessible AAV-based gene therapy products.